Metabolic Transformation of Antitumor Acridinone C-1305 but Not C-1311 via Selective Cellular Expression of UGT1A10 Increases Cytotoxic Response: Implications for Clinical Use

The acridinone derivates 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305) and 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) are promising antitumor agents with high activity against several experimental cellular and tumor models and are under evaluation in preclinical a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pawlowska, Monika, Chu, Rong, Fedejko-Kap, Barbara, Augustin, Ewa, Mazerska, Zofia, Radominska-Pandya, Anna, Chambers, Timothy C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society for Pharmacology and Experimental Therapeutics 2013
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558869/
https://ncbi.nlm.nih.gov/pubmed/23160818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.112.047811
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak